Our investigation revealed that the LDS treatment significantly induced apoptosis in human GBM cell lines, as evidenced by a decrease in Cleaved‐caspase 3/caspase 3 ratios and BCL‐2 expression, alongside an increase in BAX expression. The gene discussed is BCL2; the disease is glioblastoma.